Research programme: G protein-coupled receptor antagonists - TransTech Pharma

Drug Profile

Research programme: G protein-coupled receptor antagonists - TransTech Pharma

Alternative Names: GPCR antagonists - TransTech; Pain therapeutics - TransTech

Latest Information Update: 21 Sep 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator TransTech Pharma
  • Class
  • Mechanism of Action G protein-coupled receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Neuropathic pain

Most Recent Events

  • 21 Sep 2010 Discontinued - Preclinical for Neuropathic pain in USA (unspecified route)
  • 20 May 2005 The programme is available for licensing (http://www.ttpharma.com)
  • 08 Jul 2004 Preclinical trials in Neuropathic pain in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top